Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Definium Therapeutics Inc. Common Shares (DFTX) vs TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock (TTWO) Price & Performance

Definium Therapeutics Inc. Common SharesTrade
TAKE-TWO INTERACTIVE SOFTWARE, INC Common StockTrade

Price performance (Past 24H)

Key statistics

Definium Therapeutics Inc. Common Shares vs TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock trades at $209.7 (market cap $38.15B). The key difference: TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock is far larger — about 8.1× Definium Therapeutics Inc. Common Shares's market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock for 110 Days on average.

DFTXTTWO
Market Cap
$4.71B$38.15B
Volume
1,966,6362,207,260
Sector
HealthTechnology
52-Week High
$48.45$262.29
52-Week Low
$10.68$189.69
Typical Hold Time
0 Days110 Days
Enterprise Value
$3.67B$39.26B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Definium Therapeutics Inc. Common Shares

No Aura AI signal available yet.

TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock

Take-Two Interactive (TTWO) trades at $209.37, up 3.38% with strong analyst support (79% buy ratings) and a $292.30 consensus price target. Recent earnings show mixed results with Q1 and Q4 beats but a Q2 miss, while fundamentals reveal significant losses (-$4.48B net income in 2025) offset by robust revenue growth and anticipation for GTA VI's November launch. Technicals are bearish with resistance at $210, though the stock remains near recent highs.

The outlook hinges on GTA VI's execution, with potential for substantial upside if launch success reverses negative margins. Key risks include persistent profitability challenges, high debt levels, and competitive pressures. Institutional accumulation and positive media coverage suggest confidence in the long-term strategy, but investors must weigh near-term volatility against the transformative potential of upcoming releases.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DFTX
100% Buy0% Sell
Avg holding period · 0 Days
TTWO
5% Buy95% Sell
Avg holding period · 110 Days

Top news

Latest headlines on both assets

About Definium Therapeutics Inc. Common Shares

Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.

Read more on DFTX →

About TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock

Found in 1993, Take-Two consists of three wholly owned labels, Rockstar Games, 2K, and Zynga. The firm is one of the world's largest independent video game publishers on consoles, PCs, smartphones, and tablets. Take-Two's franchise portfolio is headlined by Grand Theft Auto (345 million units sold) and contains other well-known titles such as NBA 2K, Civilization, Borderlands, Bioshock, and Xcom. Zynga mobile titles include Farmville, Empires & Puzzles, and CSR Racing.

Read more on TTWO →